Iron serum levels and iron homeostasis parameters in patients with nosocomial pneumonia treated with cefiderocol: post hoc analysis of the APEKS-NP study

por Skaar, Eric P., Echols, Roger, Matsunaga, Yuko, Menon, Anju, Portsmouth, Simon
Publicado 2022

1285. Outcomes in Patients with Gram-Negative Bacteremia from Phase 2 and Phase 3 Clinical Trials of Cefiderocol, a Novel Siderophore Cephalosporin

por Kinoshita, David PatersonDavid PatersonMasahiro, Toyoizumi, Kiichiro, Matsunaga, Yuko, Echols, Roger
Publicado 2020

1266. Characterization of Shifts in Minimum Inhibitory Concentrations During Treatment with Cefiderocol or Comparators in the Phase 3 CREDIBLE-CR and APEKS-NP Studies

por Takemura, Miki, Yamano, Yoshinori, Matsunaga, Yuko, Ariyasu, Mari, Echols, Roger, Den Nagata, Tsutae
Publicado 2020

Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials

por Nordmann, Patrice, Shields, Ryan K., Doi, Yohei, Takemura, Miki, Echols, Roger, Matsunaga, Yuko, Yamano, Yoshinori
Publicado 2022

165. Cefiderocol Treatment for Serious Infections Caused by Carbapenem-resistant Bacteria: Post-hoc Analysis of Outcomes by Pathogen in the CREDIBLE-CR Study

por Matsunaga, Yuko, Ariyasu, Mari, Takemura, Miki, Yamano, Yoshinori, Toyoizumi, Kiichiro, Kinoshita, Masahiro, Echols, Roger, Den Nagata, Tsutae
Publicado 2020

Designing A Pathogen-Focused Study To Address The High Unmet Medical Need Represented By Carbapenem-Resistant Gram-Negative Pathogens – The International, Multicenter, Randomized,...

por Bassetti, Matteo, Ariyasu, Mari, Binkowitz, Bruce, Nagata, Tsutae Den, Echols, Roger M, Matsunaga, Yuko, Toyoizumi, Kiichiro, Doi, Yohei
Publicado 2019

1292. Safety Profile of the Novel Siderophore Cephalosporin Cefiderocol in Randomized Phase 2 and Phase 3 Clinical Studies of Serious Gram-Negative Infections

por Matsunaga, Yuko, Sonoyama, Takuhiro, Casanova, Luis, Nagata, Tsutae Den, Echols, Roger, De Gregorio, Fabio, Ogura, Eriko, Portsmouth, Simon
Publicado 2020

1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Path...

por Bassetti, Matteo, Echols, Roger, Matsunaga, Yuko, Portsmouth, Simon, Ariyasu, Mari, Toyoizumi, Kiichiro, Doi, Yohei, Doi, Yohei, Den Nagata, Tsutae
Publicado 2020

Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia

por Katsube, Takayuki, Nicolau, David P, Rodvold, Keith A, Wunderink, Richard G, Echols, Roger, Matsunaga, Yuko, Menon, Anju, Portsmouth, Simon, Wajima, Toshihiro
Publicado 2021

Erratum to: Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia

por Katsube, Takayuki, Nicolau, David P, Rodvold, Keith A, Wunderink, Richard G, Echols, Roger, Matsunaga, Yuko, Menon, Anju, Portsmouth, Simon, Wajima, Toshihiro
Publicado 2021

Mast cells contribute to double-stranded RNA-induced augmentation of airway eosinophilia in a murine model of asthma

por Kan-o, Keiko, Matsunaga, Yuko, Fukuyama, Satoru, Moriwaki, Atsushi, Hirai-Kitajima, Hiroko, Yokomizo, Takehiko, Aritake, Kosuke, Urade, Yoshihiro, Nakanishi, Yoichi, Inoue, Hiromasa, Matsumoto, Koichiro
Publicado 2013

LB4. Efficacy and Safety of Cefiderocol vs. High-Dose Meropenem in Patients with Nosocomial Pneumonia—Results of a Phase 3, Randomized, Multicenter, Double-Blind, Non-Inferiority S...

por Wunderink, Richard G, Wunderink, Richard G, Matsunaga, Yuko, Ari, Mari, Ariyasu, Mari, Echols, Roger, Echols, Roger, Menon, Anju, Den Nagata, Tsutae, Den Nagata, Tsutae
Publicado 2019

1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients

por Katsube, Takayuki, Kawaguchi, Nao, Matsunaga, Yuko, Ariyasu, Mari, Den Nagata, Tsutae, Portsmouth, Simon, Paterson, David, Paterson, David, Satlin, Michael J, Zeitlinger, Markus, Echols, Roger, Wajima, Toshihiro
Publicado 2020

Patients with MAC Lung Disease Have a Low Visceral Fat Area and Low Nutrient Intake

por Wakamatsu, Kentaro, Nagata, Nobuhiko, Maki, Sanae, Omori, Hisamitsu, Kumazoe, Hiroyuki, Ueno, Kayoko, Matsunaga, Yuko, Hara, Makiko, Takakura, Koji, Fukumoto, Nagisa, Ando, Nobuhisa, Morishige, Mami, Akasaki, Takashi, Inoshima, Ichiro, Ise, Shinji, Izumi, Miiru, Kawasaki, Masayuki
Publicado 2015

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough

por McGarvey, Lorcan, Smith, Jaclyn A., Morice, Alyn, Birring, Surinder S., Chung, Kian Fan, Dicpinigaitis, Peter V., Niimi, Akio, Benninger, Michael S., Sher, Mandel, Matsunaga, Yuko, Miyazaki, Sayaka, Machida, Mitsuaki, Ishihara, Hiroyuki, Mahmood, Adnan, Gomez, Juan-Carlos
Publicado 2022